The Drug Science Podcast16 Jun 2020

13. The Vape Debate with Gerry Stimson

The emergence of vaping and e-cigarettes is a relatively new and novel form of harm reduction. The UK has taken a scientific approach to the regulation of vaporisers and has been rewarded with great reductions of new and existing tobacco smokers. However, internationally vaporisers have been met with great distain and in some cases prohibition. In the past few years, we have seen a deliberate attempt to mislead the public over the harms of vaping nicotine and other cigarette substitute products.

Professor Gerry Stimson is a sociologist who has been promoting a harm reduction approach to public health since 1987. This began with harm reduction messaging for drug use to minimise HIV infection rates. This later expanded to other harm reduction tactics such as alcohol and tobacco control. In 2004, Gerry was appointed Emeritus Professor at Imperial College London. In 2017, he was appointed Honorary Professor at the London School of Hygiene and Tropical Medicine.

Together, Professor Nutt and Professor Stimson will unravel facts from fiction and answer:

Why are UK regulations so effective?

Should we fear ‘big tobacco’ involvement with vaporisers?

Abstinence vs harm reduction

Why is vaping stigmatised?

How does vaping change user’s relationship with nicotine?

Should we ban flavours?

Global State of Tobacco Harm Reduction

Tobacco harm reduction and the right to health

GSHR twitter

Needle exchange

What is harm reduction?

Snus

Nicotine replacement therapy

Nicotine

Drug Harm analysis

Nicotine MCDA

Public Health England e-cigarette report

US flavour ban

WHO stance on vaping

COVID and vaping

Vaping by Clive Bates

Become a Drug Science Community Member: https://www.donate.drugscience.org.uk/

Twitter: @ProfDavidNutt @Drug_Science

A Fascinate Productions podcast for Drug Science

★ Support this podcast ★

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(159)

156. Training Grandmothers to Treat Depression with Dr Dixon Chibanda

In this episode, we speak with Dr Dixon Chibanda, a psychiatrist and professor at the London School of Hygiene and Tropical Medicine. He shares how losing a patient to suicide drove him towards commun...

5 Aug 41min

155. The History of Schizophrenia with Justin Garson

In this episode of the Drug Science Podcast, Dr Hannah Thurgur speaks with Dr Justin Garson, professor of philosophy at CUNY and the author of The Madness Pill, a history of Professor Solomon Snyder a...

22 Jul 47min

154. Is Medical Cannabis Over-Prescribed? with Dr Andy Barker

Join us in this episode as Prof Nutt speaks with Dr Andy Barker, a senior psychiatrist, medical cannabis prescriber, and the co-founder of This Native Mind. Andy shares his journey into medical cannab...

8 Jul 52min

153. Psychedelics, Couples and Sex with Sarah Tilley

In this episode, we speak with Sarah Tilley, a couple’s therapy pioneer and the CEO and founder of Beautiful Space, a provider of psilocybin programmes for couples. She details how her own divorce led...

24 Jun 42min

152. Cocaine and Alcohol with David Hillier

In this episode of the Drug Science Podcast, Prof Nutt speaks with David Hillier, a journalist and the creator of the Substack WHAT ARE YOU ON. David Hillier has been writing about drug culture and m...

10 Jun 38min

151. Francis Crick: From DNA to the Brain with Prof Matthew Cobb

In this episode, we speak to Prof Matthew Cobb, professor of zoology at the University of Manchester and author of Crick: A Mind in Motion, which profiles Francis Crick. Matthew shares insights into h...

27 Mai 57min

150. Synthetic Alcohol with David Orren

Join us in this episode of the Drug Science Podcast as Prof Jo Neill speaks with David Orren, CEO of GABA Labs, which has pioneered functional drinks with SENTIA Spirits. David recounts his initial co...

13 Mai 57min

149. Psilocybin for Cancer with Dr Lauren Macdonald

In this episode, we speak to Dr Lauren Macdonald, a psychiatrist, psychedelic therapist, and group retreat facilitator. She details her path to psychedelics, in particular her cancer diagnosis that le...

29 Apr 54min